Farmacoeconomía: ¿evaluación científica o estrategia comercial?
The new global context, the dramatic rise in the cost of many health technologies, and the mounting pressures that constrain health sector budgets in most countries have created the need to evaluate health interventions, including pharmaceuticals, from an economic perspective. Pharmacoeconomics is &...
Main Author: | Velásquez Germán |
---|---|
Format: | Article |
Language: | English |
Published: |
Pan American Health Organization
1999-01-01
|
Series: | Revista Panamericana de Salud Pública |
Online Access: | http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891999000100018 |
Similar Items
Estrategia Comercial Internacional 1-AN51-200902
by: Maekawa Miyasato Cesar Daniel
Published: (2020)
by: Maekawa Miyasato Cesar Daniel
Published: (2020)
Estrategia Comercial Internacional 1-AN51-201102
by: Sifuentes Torero Emerson Jack
Published: (2020)
by: Sifuentes Torero Emerson Jack
Published: (2020)
Estrategia Comercial Internacional 2-AN47-200902
by: Maekawa Miyasato Cesar Daniel
Published: (2020)
by: Maekawa Miyasato Cesar Daniel
Published: (2020)
Similar Items
-
Farmacoeconomía: ¿evaluación científica o estrategia comercial?
by: Germán Velásquez
Published: (1999-01-01) -
Farmacoeconomia e outcomes research
by: Ermanno Attanasio
Published: (2004-09-01) -
Farmacoeconomia e malattie cardiovascolari
by: Lorenzo G. Mantovani, et al.
Published: (2007-10-01) -
La farmacoeconomía en la farmacia comunitaria
by: Sanz GAA.
Published: (2010-09-01) -
Los costes en la evaluación de intervenciones farmacéuticas. Los costes en farmacoeconomía
by: Sanz Granda A
Published: (2011-12-01)